Jpmorgan Chase & CO Avita Medical, Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Avita Medical, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 12,593 shares of RCEL stock, worth $70,772. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,593
Previous 52,706
76.11%
Holding current value
$70,772
Previous $674,000
84.87%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding RCEL
# of Institutions
78Shares Held
6.99MCall Options Held
36.4KPut Options Held
26K-
Black Rock Inc. New York, NY1.78MShares$10 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.43MShares$8.06 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA620KShares$3.48 Million0.0% of portfolio
-
State Street Corp Boston, MA527KShares$2.96 Million0.0% of portfolio
-
Opaleye Management Inc. Boston, MA440KShares$2.47 Million0.98% of portfolio
About AVITA Medical, Inc.
- Ticker RCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,030,900
- Market Cap $141M
- Description
- AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...